Effect of topology and time window on probability distribution underlying baclofen induced Ca<sup>2+</sup> response in hippocampal neurons

Saxena, Abha; Dhyani, Vaibhav; Gare, Suman; Giri, Lopamudra

doi:10.1109/embc.2019.8857601

Cited by 2 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Within a wide variety of cells, Ca 2+ serves as an almost universal ionic messenger, delivering signals received at the cell surface to the inside of the cell. These signals are controlled by the concentration of the modulating agonists and encoded in the complex spatiotemporal behavior of cytosolic Ca 2+ -concentration ([Ca c 2+ ]), ranging from stochastic spiking to regular oscillations, and more complex waveforms [13]. Ca 2+ -signals regulate the intracellular processes operating over a wide time range, from neurotransmission in microseconds to gene transcription at a scale of minutes to hours [14].…”

Section: Introductionmentioning

confidence: 99%

“…Ca 2+ mediates these functions by [Ca c 2+ ]-sensing effectors that translate Ca 2+ -signals with varying spatiotemporal dynamics into specific cellular responses [24]. In this scenario, the recent scientific efforts are focusing on drug screening and testing based on the quantification of Ca 2+ -signatures over conventional biochemical assays [13,25]. Several review papers have been published in the last three decades on the function and structure of GPCR targeting drugs as well as biomolecular details of Ca 2+ -signaling [26][27][28].…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

GPCR mediated control of calcium dynamics: A systems perspective

Dhyani

Gare

Gupta

et al. 2020

Cellular Signalling

Self Cite

View full text Add to dashboard Cite

G-protein coupled receptor (GPCR) mediated calcium (Ca 2+)-signaling transduction remains crucial in designing drugs for various complex diseases including neurodegeneration, chronic heart failure as well as respiratory diseases. Although there are several reviews detailing various aspects of Ca 2+-signaling such as the role of IP 3 receptors and Ca 2+-induced-Ca 2+-release, none of them provide an integrated view of the mathematical descriptions of GPCR signal transduction and investigations on dose-response curves. This article is the first study in reviewing the network structures underlying GPCR signal transduction that control downstream [Ca c 2+ ]oscillations. The central theme of this paper is to present the biochemical pathways, as well as molecular mechanisms underlying the GPCR-mediated Ca 2+-dynamics in order to facilitate a better understanding of how agonist concentration is encoded in Ca 2+-signals for G αq , G αs , and G αi/o signaling pathways. Moreover, we present the GPCR targeting drugs that are relevant for treating cardiac, respiratory, and neuro-diseases. The current paper presents the ODE formulation for various models along with the detailed schematics of signaling networks. To provide a systems perspective, we present the network motifs that can provide readers an insight into the complex and intriguing science of agonist-mediated Ca 2+-dynamics. One of the features of this review is to pinpoint the interplay between positive and negative feedback loops that are involved in controlling intracellular [Ca c 2+ ]-oscillations. Furthermore, we review several examples of dose-response curves obtained from [Ca c 2+ ]-spiking for various GPCR pathways. This paper is expected to be useful for pharmacologists and computational biologists for designing clinical applications of GPCR targeting drugs through modulation of Ca 2+dynamics.

show abstract

Section: Introductionmentioning

confidence: 99%